| Initial invasive or conservative strategy for stable coronary disease DJ Maron, JS Hochman, HR Reynolds, S Bangalore, SM O’Brien, ... New England Journal of Medicine 382 (15), 1395-1407, 2020 | 1985 | 2020 |
| Fixed-dose combinations improve medication compliance: a meta-analysis S Bangalore, G Kamalakkannan, S Parkar, FH Messerli The American journal of medicine 120 (8), 713-719, 2007 | 1556 | 2007 |
| 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical … Writing Committee Members, JS Lawton, JE Tamis-Holland, S Bangalore, ... Journal of the American College of Cardiology 79 (2), e21-e129, 2022 | 1450 | 2022 |
| Renin–angiotensin–aldosterone system inhibitors and risk of Covid-19 HR Reynolds, S Adhikari, C Pulgarin, AB Troxel, E Iturrate, SB Johnson, ... New England Journal of Medicine 382 (25), 2441-2448, 2020 | 1226 | 2020 |
| ST-segment elevation in patients with Covid-19—a case series S Bangalore, A Sharma, A Slotwiner, L Yatskar, R Harari, B Shah, ... New England Journal of Medicine 382 (25), 2478-2480, 2020 | 929 | 2020 |
| Diabetes and hypertension: a position statement by the American Diabetes Association IH De Boer, S Bangalore, A Benetos, AM Davis, ED Michos, P Muntner, ... Diabetes care 40 (9), 1273-1284, 2017 | 824 | 2017 |
| 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee … JS Lawton, JE Tamis-Holland, S Bangalore, ER Bates, TM Beckie, ... Circulation 145 (3), e4-e17, 2022 | 764* | 2022 |
| Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry RP Barbaro, G MacLaren, PS Boonstra, TJ Iwashyna, AS Slutsky, E Fan, ... The Lancet 396 (10257), 1071-1078, 2020 | 723 | 2020 |
| Short-and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials S Bangalore, S Kumar, M Fusaro, N Amoroso, MJ Attubato, F Feit, ... Circulation 125 (23), 2873-2891, 2012 | 695 | 2012 |
| Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial M Azizi, RE Schmieder, F Mahfoud, MA Weber, J Daemen, J Davies, ... The Lancet 391 (10137), 2335-2345, 2018 | 673 | 2018 |
| Obesity paradox in patients with hypertension and coronary artery disease S Uretsky, FH Messerli, S Bangalore, A Champion, RM Cooper-DeHoff, ... The American journal of medicine 120 (10), 863-870, 2007 | 671 | 2007 |
| Atrial fibrillation and obesity—results of a meta-analysis N Wanahita, FH Messerli, S Bangalore, AS Gami, VK Somers, ... American heart journal 155 (2), 310-315, 2008 | 646 | 2008 |
| β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease S Bangalore, G Steg, P Deedwania, K Crowley, KA Eagle, S Goto, ... Jama 308 (13), 1340-1349, 2012 | 604 | 2012 |
| Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized … S Bangalore, S Kumar, I Lobach, FH Messerli Circulation 123 (24), 2799-2810, 2011 | 592 | 2011 |
| Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review MJ Sarnak, K Amann, S Bangalore, JL Cavalcante, DM Charytan, ... Journal of the American College of Cardiology 74 (14), 1823-1838, 2019 | 568 | 2019 |
| The transition from hypertension to heart failure: contemporary update FH Messerli, SF Rimoldi, S Bangalore JACC: Heart Failure 5 (8), 543-551, 2017 | 547 | 2017 |
| Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis S Bangalore, J Wetterslev, S Pranesh, S Sawhney, C Gluud, FH Messerli The Lancet 372 (9654), 1962-1976, 2008 | 499 | 2008 |
| Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials S Bangalore, S Kumar, SE Kjeldsen, H Makani, E Grossman, J Wetterslev, ... The lancet oncology 12 (1), 65-82, 2011 | 423 | 2011 |
| J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial S Bangalore, FH Messerli, CC Wun, AL Zuckerman, D DeMicco, JB Kostis, ... European heart journal 31 (23), 2897-2908, 2010 | 412 | 2010 |
| Relation of beta-blocker–induced heart rate lowering and cardioprotection in hypertension S Bangalore, S Sawhney, FH Messerli Journal of the American College of Cardiology 52 (18), 1482-1489, 2008 | 403 | 2008 |
Deepak L. Bhatt, MD, MPH, MBADr. Valentin Fuster Professor of Cardiovascular Medicine, Icahn School of Medicine at Mount Sinai在 post.harvard.edu 的电子邮件经过验证
